Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving SNDL Inc. and its officers or directors [1] Group 1: Company Developments - On December 15, 2025, SNDL announced an amendment to its agreement to acquire 32 cannabis retail stores from 1CM Inc., maintaining a total purchase price of $32.2 million in cash, but splitting the acquisition into two closings for regulatory approval [3] - Following the announcement of the amended agreement, SNDL's stock price decreased by $0.29 per share, or 13.12%, closing at $1.92 per share on the same day [3]

Core Viewpoint - 1933 Industries Inc. has provided an update on its unsecured convertible debentures issued in 2024, highlighting the conversion status and its impact on the company's financial position [1][2][3]. Debenture Conversion Status - As of December 22, 2025, a total of $1,035,000 of debentures were converted into units of the company, leaving $1,563,000 of debentures outstanding [2]. Financial Position and Liquidity - The company acknowledges the conversions have reduced outstanding debt obligations and strengthened its balance sheet [3]. - The available cash resources are essential for ongoing operations, and the company lacks sufficient liquidity to repay the outstanding principal amount of the 2024 Debentures in cash without impairing operations [4]. - Despite reporting positive operating results and net income, maintaining adequate working capital is critical for day-to-day operations [5]. Management Commentary - The CEO stated that the completed conversions have helped preserve liquidity necessary for ongoing operations and that the company will continue to monitor its financial position and capital structure [6]. Company Overview - 1933 Industries is a licensed producer based in Nevada, focusing on the cultivation and extraction of cannabis consumer products under its flagship brand, Alternative Medicine Association (AMA) [7].

Company Overview - NewLake Capital Partners (NLCP) is a U.S. REIT operating in the highly regulated cannabis industry, focusing on both indoor cultivation assets and dispensaries [1] Investment Focus - The company emphasizes a "Growth at a Reasonable Price" strategy, analyzing fundamentals and identifying catalysts that could drive significant alpha over a medium-term horizon [1] Market Position - NLCP operates in a sector characterized by strict regulations, which may impact its operational flexibility and growth potential [1]

Company Overview - NewLake Capital Partners (NLCP) is a U.S. REIT operating in the highly regulated cannabis industry, focusing on indoor cultivation assets and dispensaries [1] Investment Focus - The company emphasizes a "Growth at a Reasonable Price" strategy, analyzing fundamentals and identifying catalysts for potential medium-term alpha [1] Market Position - NLCP is positioned within a niche market that combines real estate investment with the growing cannabis sector, which is subject to regulatory scrutiny [1]

Core Viewpoint - LEEF Brands, Inc. has successfully completed the early conversion of all outstanding Canadian-dollar-denominated convertible debentures, totaling approximately CAD $237 million, which enhances the company's financial flexibility and supports future growth initiatives [1][3][9]. Financial Summary - The early conversion involved debenture holders settling their debentures into units at a conversion price of CAD $0.25 per unit, resulting in the issuance of approximately 946,309 units [2]. - The company reported a 24% year-over-year revenue growth and a doubling of gross margins in Q3, indicating strong operational momentum [3]. Management Commentary - The CEO of the company expressed gratitude towards debenture holders for their support and highlighted that the elimination of convertible debentures marks a new chapter for the company, allowing for enhanced balance sheet flexibility [4]. Strategic Rationale - The full early conversion strengthens the balance sheet by removing the remaining CAD convertible debenture debt, which positions the company for strategic growth initiatives in California and New York [9]. - The company retains two pieces of real estate debt, one for $4.2 million at 4% interest and another for $7 million at 0% interest, indicating manageable debt levels [9]. Company Overview - LEEF Brands, Inc. is a vertically integrated, multistate cannabis operator focused on extraction, manufacturing, cultivation, and product innovation, with operations in California and New York [5].

Core Insights - The cannabis industry is evolving into a larger and more regulated global market, with increasing legalization trends in the U.S. and internationally, creating long-term investment opportunities for marijuana stock investors [1] - Adult use markets are driving scale efficiency and brand dominance, with federal reform discussions potentially unlocking institutional capital by 2026 [2] - Strong balance sheets and leadership distinguish successful companies, while diversification across cannabis segments can reduce portfolio risk [3] Industry Overview - The cannabis market is experiencing growth due to rising consumer demand and acceptance, with medical cannabis adoption providing consistent revenue [1] - Regulatory clarity expected in 2026 could significantly impact investor sentiment and valuations, making marijuana stocks volatile but potentially rewarding for disciplined long-term investors [2] - The cannabis industry remains undervalued relative to its growth potential, with macroeconomic stabilization possibly supporting stock performance [3] Company Highlights - Green Thumb Industries Inc. reported Q3 2025 financials with revenue of $291.4 million, a 1.6% increase year-over-year, and a GAAP net income of $23.3 million [7] - Curaleaf Holdings, Inc. has expanded its retail presence by opening a second dispensary in Millcreek, Pennsylvania, increasing its footprint to 18 stores in the state and 159 nationwide [10]

Group 1 - 420 Investor was launched in 2013, coinciding with Colorado's legalization of cannabis for adult use, and has since moved its service to Seeking Alpha [1] - Glass House Brands (GLASF) is highlighted as a popular cannabis stock based in California, which has outperformed many other cannabis stocks in recent years [1] - Alan Brochstein, CFA, is recognized as a pioneer in the cannabis investment sector, having founded AB Analytical Services in 2007 and managing the investing group 420 Investor since 2013 [1] Group 2 - The investing group 420 Investor covers 20 cannabis stocks, providing investment news, earnings report previews, and post-report analyses [1] - Features of the group include a model portfolio, 10 weekly videos with chart analysis, 3 weekly summary pieces, a monthly newsletter, and a chat function for investor questions [1]

Industry Overview - The cannabis industry is entering a critical growth phase, with 2026 positioned as a pivotal year for long-term investors in marijuana stocks [1] - The legal cannabis market is showing signs of structural improvement driven by policy reform, consolidation, and expanding global demand [1][2] Regulatory Developments - A significant development is the U.S. federal government's move to reschedule marijuana, which is expected to lead to meaningful improvements in profitability for top marijuana stocks [2] - Reduced tax pressure and enhanced transparency are making cannabis stocks more attractive to institutional investors [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. The company welcomed the reclassification of marijuana to Schedule III under the Controlled Substances Act [4][5] - **Curaleaf Holdings, Inc.**: Produces and distributes cannabis products in the U.S. and internationally. Recently relocated its Bradford, Pennsylvania dispensary to a new expanded location in Erie, maintaining a footprint of 18 stores in Pennsylvania and 159 locations nationwide [6][8] - **Cresco Labs Inc.**: Cultivates, manufactures, and sells retail and medical cannabis products in the U.S. and Germany. The CEO highlighted the rescheduling of cannabis as a cultural turning point, reflecting the support of nearly 90% of Americans for some form of cannabis legalization [10]

Core Insights - Shares of Green Thumb Industries (GTBIF) increased nearly 35% in the past month due to an executive order by President Trump to reschedule marijuana at the federal level [1][11] - The executive order directs federal agencies to expedite the reclassification of marijuana from Schedule I to Schedule III, acknowledging its medical value and representing a significant regulatory shift for the U.S. cannabis industry [3][6] - Rescheduling could improve long-term profitability for operators like Green Thumb by eliminating IRS Code 280E, which currently inflates effective tax rates [4][11] Regulatory Developments - The executive order marks a positive regulatory shift, although it does not provide a specific implementation timeline or address federal legalization of adult-use cannabis [6] - The reclassification may support broader medical research efforts and enhance the legitimacy of cannabis-based therapies, benefiting established operators with consumer packaged goods and medical portfolios [5] Financial Performance - Green Thumb's Q3 2025 revenues rose nearly 2% year over year to over $291 million, driven by strength in its CPG portfolio and contributions from new adult-use markets [9] - Comparable store sales declined 7% during the quarter due to pricing pressure and increased competition, while gross margin fell 200 basis points to 49.4% [10][11] - Despite these challenges, EPS (excluding one-time gains) remained flat year over year at 4 cents, indicating operational resilience [10] Competitive Landscape - Green Thumb operates in a highly competitive U.S. cannabis market, facing pricing pressures and competition from peers like Canopy Growth and Cresco Labs [13] - Unlike its competitors, Green Thumb is fully reliant on the U.S. market, which is fragmented and crowded, limiting its growth avenues compared to those expanding internationally [14] Future Outlook - The company is expected to remain under pressure due to persistent pricing compression in maturing markets, with management anticipating Q4 2025 revenues to be flat or up low single digits [12] - While marijuana reclassification is a significant policy milestone, it does not fundamentally change the near-term operating outlook for cannabis companies focused on adult-use markets [18] - Existing shareholders may maintain exposure in anticipation of long-term reform, but prospective investors are advised to wait for clearer evidence of sustainable earnings growth [19]

Group 1 - Village Farms (VFF) is shifting from a low-margin grower to a cannabis regulatory platform, focusing on cost structure and distribution discipline rather than packaging or branding [1] - Investors continue to treat Village Farms as a traditional grower despite its transition to a regulatory platform [1] Group 2 - The investment strategy discussed combines technical analysis with the CAN SLIM methodology to identify high-growth companies often overlooked by mainstream analysts [1] - The research process integrates both fundamental and technical perspectives, paying attention to indicators such as relative strength, unusual trading volume, and earnings acceleration [1] - The goal is to spot opportunities early before broader market recognition drives prices higher [1]